===== AADI Info =====
**address1:** 17383 Sunset Boulevard
**address2:** Suite A250
**city:** Pacific Palisades
**state:** CA
**zip:** 90272
**country:** United States
**phone:** 424 744 8055
**website:** https://aadibio.com
**industry:** Biotechnology
**industryKey:** biotechnology
**industryDisp:** Biotechnology
**sector:** Healthcare
**sectorKey:** healthcare
**sectorDisp:** Healthcare
**longBusinessSummary:** Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa. The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.
**fullTimeEmployees:** 70
**companyOfficers:** [{'maxAge': 1, 'name': 'Dr. Neil P. Desai Ph.D.', 'age': 58, 'title': 'Founder & Executive Chairman', 'yearBorn': 1965, 'fiscalYear': 2023, 'totalPay': 710346, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. David J. Lennon Ph.D.', 'age': 52, 'title': 'President, CEO & Director', 'yearBorn': 1971, 'fiscalYear': 2023, 'totalPay': 277753, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Scott M. Giacobello CPA', 'age': 53, 'title': 'CFO, Treasurer, Investor Relations & Corporate Communications', 'yearBorn': 1970, 'fiscalYear': 2023, 'totalPay': 643230, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Loretta M. Itri F.A.C.P., M.D.', 'age': 73, 'title': 'Chief Medical Officer', 'yearBorn': 1950, 'fiscalYear': 2023, 'totalPay': 617451, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Stephen M. Rodin J.D.', 'age': 47, 'title': 'Senior VP of Legal & General Counsel', 'yearBorn': 1976, 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Raymond G. Steitz', 'age': 64, 'title': 'Senior VP of Human Resources & Chief Human Resources Officer', 'yearBorn': 1959, 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Bryan  Ball', 'age': 53, 'title': 'Chief Technical Operations Officer', 'yearBorn': 1970, 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}]
**auditRisk:** 3
**boardRisk:** 6
**compensationRisk:** 9
**shareHolderRightsRisk:** 8
**overallRisk:** 8
**governanceEpochDate:** 1722470400
**compensationAsOfEpochDate:** 1703980800
**maxAge:** 86400
**priceHint:** 4
**previousClose:** 1.45
**open:** 1.43
**dayLow:** 1.43
**dayHigh:** 1.48
**regularMarketPreviousClose:** 1.45
**regularMarketOpen:** 1.43
**regularMarketDayLow:** 1.43
**regularMarketDayHigh:** 1.48
**beta:** 0.31
**forwardPE:** -0.6475771
**volume:** 29012
**regularMarketVolume:** 29012
**averageVolume:** 199890
**averageVolume10days:** 108640
**averageDailyVolume10Day:** 108640
**bid:** 1.45
**ask:** 1.49
**bidSize:** 100
**askSize:** 400
**marketCap:** 36183756
**fiftyTwoWeekLow:** 1.21
**fiftyTwoWeekHigh:** 7.24
**priceToSalesTrailing12Months:** 1.5192407
**fiftyDayAverage:** 1.5312
**twoHundredDayAverage:** 2.299075
**currency:** USD
**enterpriseValue:** -41820492
**profitMargins:** -2.7477398
**floatShares:** 16148562
**sharesOutstanding:** 24614800
**sharesShort:** 188343
**sharesShortPriorMonth:** 747037
**sharesShortPreviousMonthDate:** 1719532800
**dateShortInterest:** 1722384000
**sharesPercentSharesOut:** 0.0077
**heldPercentInsiders:** 0.10786
**heldPercentInstitutions:** 0.45993
**shortRatio:** 1.19
**shortPercentOfFloat:** 0.0113
**impliedSharesOutstanding:** 24614800
**bookValue:** 3.201
**priceToBook:** 0.4592315
**lastFiscalYearEnd:** 1703980800
**nextFiscalYearEnd:** 1735603200
**mostRecentQuarter:** 1719705600
**netIncomeToCommon:** -65443000
**trailingEps:** -2.43
**forwardEps:** -2.27
**lastSplitFactor:** 1:15
**lastSplitDate:** 1630022400
**enterpriseToRevenue:** -1.756
**enterpriseToEbitda:** 0.593
**52WeekChange:** -0.7578254
**SandP52WeekChange:** 0.2623955
**exchange:** NCM
**quoteType:** EQUITY
**symbol:** AADI
**underlyingSymbol:** AADI
**shortName:** Aadi Bioscience, Inc.
**longName:** Aadi Bioscience, Inc.
**firstTradeDateEpochUtc:** 1518791400
**timeZoneFullName:** America/New_York
**timeZoneShortName:** EDT
**uuid:** dc15d255-5620-3e50-9851-9151504cc320
**messageBoardId:** finmb_430225247
**gmtOffSetMilliseconds:** -14400000
**currentPrice:** 1.47
**targetHighPrice:** 14.0
**targetLowPrice:** 5.0
**targetMeanPrice:** 10.0
**targetMedianPrice:** 11.0
**recommendationMean:** 1.8
**recommendationKey:** buy
**numberOfAnalystOpinions:** 3
**totalCash:** 78568000
**totalCashPerShare:** 3.192
**ebitda:** -70472000
**totalDebt:** 1056000
**quickRatio:** 3.815
**currentRatio:** 4.199
**totalRevenue:** 23817000
**debtToEquity:** 1.34
**revenuePerShare:** 0.883
**returnOnAssets:** -0.34932
**returnOnEquity:** -0.62264
**freeCashflow:** -29938250
**operatingCashflow:** -50405000
**revenueGrowth:** -0.004
**grossMargins:** -1.2839999
**ebitdaMargins:** -2.95889
**operatingMargins:** -2.52209
**financialCurrency:** USD
**trailingPegRatio:** None